Resolve Coal Pty Ltd
Overview
Resolve Coal is a Brisbane based coal exploration and development company with over 20 years of providing coal projects throughout the world. Resolve Coal have worked on the greenfield target generation and technical delivery of a number of developing and producing coal mines in Australia, British Columbia, Colombia, China, Mongolia and more.
Resolve Coal is proud to present the Hyde Park and Bully Creek Coal Projects to astute investors. Some key highlights:
* 315 Mt JORC Indicated, 1.3Bt JORC Inferred Resource
* Low Product Strip ratio of 4.5/1-8/1 (BCM/T)
* ~ 5600 Kcal/Kg (NAR), 11% Ash, 0.3% S
* Access to rail and port
Market Opportunity
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque. Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.
Proin neque lacus, semper vel ex at, eleifend rhoncus est.
Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a.
Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.
Nam vitae varius augue. Nam pharetra faci
Use of Funds
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat,
Overview
Resolve Coal is a Brisbane based coal exploration and development company with over 20 years of providing coal projects throughout the world. Resolve Coal have worked on the greenfield target generation and technical delivery of a number of developing and producing coal mines in Australia, British Columbia, Colombia, China, Mongolia and more.
Resolve Coal is proud to present the Hyde Park and Bully Creek Coal Projects to astute investors. Some key highlights:
* 315 Mt JORC Indicated, 1.3Bt JORC Inferred Resource
* Low Product Strip ratio of 4.5/1-8/1 (BCM/T)
* ~ 5600 Kcal/Kg (NAR), 11% Ash, 0.3% S
* Access to rail and port
Market Opportunity
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque. Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.
Proin neque lacus, semper vel ex at, eleifend rhoncus est.
Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a.
Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.
Nam vitae varius augue. Nam pharetra faci
Use of Funds
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat,
See more exiting opportunities on CapitalHQ
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...
ProxyTwin
ProxyTwin™ amplifies expertise. ProxyTwin is a digital twin that works for experts so they can help more people. We create advanced digital replicas of real individuals, enabling them to virtually attend meetings, deliver messages, and hold thousands of interactions simultaneously. Recently...
HorizonTwo Capital Partners
HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.
The Insides Company
First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.
DCARB
We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.
Grabba Technologies Pty Ltd
Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.
Backed By Leading Investment Groups and Family Offices
